Title Authors Journal Volume (Year)
Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells. Croucher DR, et. al. Mol Cell Biol 30 (2010)